The much-anticipated guideline is now available for RQA members.
More information
Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More information22nd July 2026
The European Medicines Agency has published for public consultation a draft reflection paper on particulars for safety signals for (traditional) herbal medicinal products.
This reflection paper discusses particular aspects to be considered for safety signals for herbal medicinal products, including traditional herbal medicinal products, in addition to established EMA guidance documents. It should be read in conjunction with Directive 2001/83/EC, Regulation (EC) No 726/2004 and Commission Implementing Regulation (EU) No 520/2012, as well as relevant guidelines on GVP. The guidance published as GVP is the principal guidance supporting implementation of, and compliance with, legal requirements.
For more information on this please click here.
Comments should be provided by 15 October 2026 using this template.
The EMA may collect and further process some personal data of stakeholders and interested parties who submit contributions to the consultations. For more information, see Specific privacy statement for public and targeted consultations.